1. Home
  2. SION vs NWTN Comparison

SION vs NWTN Comparison

Compare SION & NWTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • NWTN
  • Stock Information
  • Founded
  • SION 2019
  • NWTN 2016
  • Country
  • SION United States
  • NWTN United Arab Emirates
  • Employees
  • SION N/A
  • NWTN N/A
  • Industry
  • SION
  • NWTN Auto Manufacturing
  • Sector
  • SION
  • NWTN Consumer Discretionary
  • Exchange
  • SION NYSE
  • NWTN Nasdaq
  • Market Cap
  • SION 564.4M
  • NWTN 534.7M
  • IPO Year
  • SION 2025
  • NWTN N/A
  • Fundamental
  • Price
  • SION $13.69
  • NWTN $1.53
  • Analyst Decision
  • SION Strong Buy
  • NWTN
  • Analyst Count
  • SION 1
  • NWTN 0
  • Target Price
  • SION $32.00
  • NWTN N/A
  • AVG Volume (30 Days)
  • SION 143.7K
  • NWTN 3.3M
  • Earning Date
  • SION 05-12-2025
  • NWTN 01-01-0001
  • Dividend Yield
  • SION N/A
  • NWTN N/A
  • EPS Growth
  • SION N/A
  • NWTN N/A
  • EPS
  • SION N/A
  • NWTN N/A
  • Revenue
  • SION N/A
  • NWTN $43,867,000.00
  • Revenue This Year
  • SION N/A
  • NWTN N/A
  • Revenue Next Year
  • SION N/A
  • NWTN N/A
  • P/E Ratio
  • SION N/A
  • NWTN N/A
  • Revenue Growth
  • SION N/A
  • NWTN 7424.36
  • 52 Week Low
  • SION $7.26
  • NWTN $0.30
  • 52 Week High
  • SION $25.19
  • NWTN $3.56
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • NWTN 53.74
  • Support Level
  • SION N/A
  • NWTN $1.50
  • Resistance Level
  • SION N/A
  • NWTN $2.36
  • Average True Range (ATR)
  • SION 0.00
  • NWTN 0.54
  • MACD
  • SION 0.00
  • NWTN 0.01
  • Stochastic Oscillator
  • SION 0.00
  • NWTN 32.29

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About NWTN NWTN Inc.

NWTN Inc is a pioneering smart electric vehicle company which aims to integrate avant-garde design, life-style personalization, IoT connectivity, and autonomous driving technology into a passenger-centric green premium mobility solution to the world. Geographically, it operates in The United States, The United Arab Emirates, Mainland China.

Share on Social Networks: